Table 1 Study cohort characteristics, interventions within 72 h of hospital stay and 30-days outcome. All values are presented as n (%) unless stated otherwise.
All patients | Younger (< 40 years) | Older (≥ 40 years) | |
|---|---|---|---|
Male/female | 280/138 (67/33%) | 111/64 (63/37%) | 169/74 (70/30%) |
Age, years (median, (iqr)) | 44 (34) | 25 (11) | 57 (22)*** |
Pre-admission medical treatment | |||
Platelet inhibitors | 27 (6%) | 1 (1%) | 26 (11%)*** |
Anticoagulants | 24 (6%) | 0 | 24 (10%) |
Vitamin-K antagonists | 12 (3%) | 0 | 12 (5%) |
Direct oral anticoagulants | 10 (2%) | 0 | 10 (4%) |
Unspecified | 2 (0.5%) | 0 | 2 (1%) |
Antihypertensiva | 57 (14%) | 2 (1%) | 55 (23%)*** |
Admission | |||
Primary admissions | 385 (92%) | 164 (94%) | 221 (91%) |
Intubated on admission | 52 (12%) | 18 (10%) | 34 (14%) |
Temperature < 35 °C, n = 99 | 5 (5%) | 1 (1%) | 4 (4%) |
Shock Index (HR/systolic blood pressure) ≥ 0.8, n = 351 | 43 (12%) | 20 (14%) | 23 (11%) |
Respiratory rate ≥ 25/min, n = 196 | 10 (5%) | 3 (4%) | 7 (6%) |
Time from trauma to admission, median (iqr), min | 55 (37–76) | 50 (35–71) | 60 (42–79)** |
Trauma mechanism | |||
Blunt | 364 (87%) | 143 (82%) | 221 (91%)** |
Penetrating | 17 (4%) | 14 (8%) | 3 (1%)** |
Combined | 4 (1%) | 4 (4%) | 0* |
Unknown | 33 (8%) | 14 (8%) | 19 (8%) |
Trauma severity | |||
Injury severity score | |||
0–8 | 209 (50%) | 112 (65%) | 97 (40%)*** |
9–15 | 93 (22%) | 27 (15%) | 66 (27%)** |
16–24 | 51 (12%) | 13 (7%) | 38 (16%)* |
25–75 | 54 (13%) | 16 (9%) | 38 (16%) |
Unknown | 11 (3%) | 7 (3%) | 4 (2%) |
Patients operated within 72 hours1 | |||
One round of surgery | 126 (30%) | 44 (25%) | 82 (34%) |
Repeated rounds of surgery | 28 (7%) | 8 (5%) | 20 (8%) |
Surgical procedures within 72 hours2 | |||
Orthopedic surgery | 76 (32%) | 27 (12%) | 49 (21%) |
Neuro surgery | 43 (18%) | 19 (8%) | 24 (10%) |
Spine surgery | 27 (10%) | 7 (3%) | 20 (9%) |
Thoracic surgery | 26 (11%) | 6 (3%) | 20 (9%)* |
General surgery | 20 (9%) | 7 (3%) | 13 (6%) |
Minor superficial procedures | 19 (8%) | 9 (4%) | 10 (4%) |
Interventional radiology | 14 (6%) | 3 (1%) | 11 (5%) |
Facial surgery | 9 (4%) | 6 (3%) | 3 (1%) |
Medical interventions within 72 hours3 | |||
Blood transfusion | 38 (9%) | 11 (6%) | 27 (11%) |
Massive blood transfusions | 15 (4%) | 6 (3%) | 9 (4%) |
Thromboprophylaxis | 146 (35%) | 43 (25%) | 103 (42%)*** |
Initiated before 72 h | 123 (29%) | 34 (19%) | 89 (37%)*** |
Initiated after 72 h | 23 (6%) | 9 (5%) | 14 (6%)* |
30-days outcome | |||
Dead | 15 (4%) | 4 (2%) | 11 (5%) |
Any thromboembolic event | 12 (3%) | 0 | 12 (5%)** |
Venous | 7 (2%) | 0 | 7 (3%)** |
Arterial | 5 (1%) | 0 | 5 (2%)** |